Praxis Precision Medicines (PRAX) Assets (2019 - 2026)

Praxis Precision Medicines' Assets history runs 8 years deep, the most recent figure standing at $1.5 billion for Q1 2026.

• On a quarterly basis, Assets rose 205.01% year-over-year to $1.5 billion in Q1 2026; TTM through Mar 2026 was $1.5 billion, a 205.01% increase from a year earlier, with the FY2025 full-year figure at $937.9 million, up 94.14% from the prior year.
• Assets rose to $1.5 billion in Q1 2026 per PRAX's latest filing, from $937.9 million in the prior quarter.
• Across five years, Assets topped out at $1.5 billion in Q1 2026 and bottomed at $87.9 million in Q4 2023.
• The 5-year median for Assets is $250.4 million (2024), against an average of $377.4 million.
• Across the five-year window, Assets slumped 60.67% in 2022 and jumped 449.31% in 2024, its largest moves.
• Year by year, Assets stood at $115.1 million in 2022, then declined by 23.61% to $87.9 million in 2023, then soared by 449.31% to $483.1 million in 2024, then jumped by 94.14% to $937.9 million in 2025, then jumped by 55.69% to $1.5 billion in 2026.
• Per Business Quant, the three latest PRAX Assets figures stand at $1.5 billion (Q1 2026), $937.9 million (Q4 2025), and $396.4 million (Q3 2025).